Archer Daniels Midland Company (ADM) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Q4 2024 adjusted EPS was $1.14, down 16% year-over-year; full-year adjusted EPS was $4.74, down 32% year-over-year, meeting guidance midpoint.
Total segment operating profit was $1.1B for Q4 2024 (down 16% YoY) and $4.2B for the year (down 28% YoY).
Cash flows from operations before working capital for FY 2024 were $3.3B, down 30% year-over-year.
Achieved strong crush volumes in canola, rapeseed, and LATAM; improved North American soy operations and reduced unplanned downtime.
Increased quarterly dividend, marking 93 consecutive years of uninterrupted dividends, and announced $500–$750M targeted cost savings.
Financial highlights
Q4 2024 revenue was $21.5B, down from $23.0B in Q4 2023; FY 2024 revenue was $85.5B, down from $93.9B in FY 2023.
FY 2024 net earnings attributable to ADM were $1.8B, down from $3.5B in FY 2023; adjusted EBITDA for FY 2024 was $4.5B, down from $6.2B.
Q4 segment operating profit: $1.1B; full-year: $4.2B.
Returned $3.3B to shareholders via dividends and repurchases; $1.6B in capex; $1B to M&A.
Adjusted net debt/adjusted EBITDA ratio increased to 2.0x from 0.9x year-over-year.
Outlook and guidance
2025 adjusted EPS expected between $4.00–$4.75, reflecting weaker market fundamentals and ongoing policy uncertainty.
Q1 2025 AS&O segment profit expected down ~50% YoY; full-year AS&O profit to be below or similar to 2024.
Carbohydrate Solutions Q1 profit expected down 5%–15% YoY; full-year profit expected lower than 2024.
Nutrition Q1 profit expected down 50% YoY; full-year profit expected higher with low to mid-single-digit revenue growth.
$200M–$300M in cost savings targeted for 2025; $500M–$750M over 3–5 years.
Latest events from Archer Daniels Midland Company
- Growth in decarbonization and innovation offsets market pressures, with Brazil as a key focus.ADM
Bank of America 2026 Global Agriculture and Materials Conference25 Feb 2026 - 2026 guidance targets EPS growth and improved performance despite prior year declines.ADM
Q4 20253 Feb 2026 - Earnings and margins fell, but capital returns and full-year EPS guidance held steady.ADM
Q2 20242 Feb 2026 - Growth outlook remains robust, with cost savings, automation, and Nutrition gains driving performance.ADM
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 2024 earnings plunged on a $461M Wilmar impairment and lower segment profits.ADM
Q3 202412 Jan 2026 - Strong Q2, cost cuts, and Nutrition recovery set up a positive 2025–2026 outlook.ADM
Barclays 18th Annual Global Consumer Staples Conference 20255 Jan 2026 - Policy clarity and operational improvements set the stage for margin growth in 2026.ADM
Goldman Sachs Industrials and Materials Conference 20254 Dec 2025 - Strong financials, board refreshment, and enhanced ESG; board opposes easing special meeting rules.ADM
Proxy Filing1 Dec 2025 - Key votes include director elections, say-on-pay, auditor ratification, and a shareholder rights proposal.ADM
Proxy Filing1 Dec 2025